Adam Penfold
Medical · Spencer, WVNPI 1023423613
Payments from drug & device makers
Across 100 payments — averaging $15.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$393
- Amgen$180
- Pfizer$134
- Biohaven Pharmaceuticals, Inc.$126
- GSK$97
- Abbott$79
- plus $532 from 17 others
What the payments were for
- Food & beverage$1,541100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $393 |
| Amgen | 14 | $180 |
| Pfizer | 8 | $134 |
| Biohaven Pharmaceuticals, Inc. | 6 | $126 |
| GSK | 7 | $97 |
| Abbott | 5 | $79 |
| Sanofi-aventis U.S. LLC | 5 | $75 |
| Merck | 4 | $49 |
| Lilly USA, LLC | 3 | $42 |
| Kowa Pharmaceuticals America, Inc. | 3 | $38 |
| AstraZeneca | 3 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Novartis | 2 | $33 |
| Averitas Pharma Inc. | 1 | $33 |
| Novo Nordisk | 2 | $32 |
| Daiichi Sankyo Inc. | 2 | $30 |
| Medicure Pharma Inc. | 1 | $29 |
| Boehringer Ingelheim | 2 | $26 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Eisai Inc. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
| Organon | 2 | $13 |
How this compares
$1,541 in reported general payments places this provider in the 65th percentile of 233 medical providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 32 | $59,675 |
| JardianceEmpagliflozin | 49 | $55,295 |
| TrulicityDulaglutide | 21 | $35,288 |
| XareltoRivaroxaban | 30 | $32,528 |
| LinzessLinaclotide | 26 | $31,779 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $27,451 |
| MounjaroTirzepatide | 16 | $25,716 |
| EliquisApixaban | 15 | $18,863 |
| Tresiba Flextouch U-200Insulin Degludec | 13 | $12,836 |
| SymbicortBudesonide/Formoterol Fumarate | 24 | $6,483 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $5,222 |
| Novolog FlexpenInsulin Aspart | 14 | $4,665 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 114 | $3,281 |
| Celecoxib | 49 | $2,915 |
| Ventolin HfaAlbuterol Sulfate | 46 | $2,575 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $42 | $61,00437 claims |
| Novo NordiskOzempic | $32 | $59,67532 claims |
| Boehringer IngelheimJardiance | $26 | $55,29549 claims |
| Johnson & JohnsonXarelto | $14 | $32,52830 claims |
| AbbVieLinzess | $393 | $31,77926 claims |
| GSKTrelegy Ellipta | $97 | $27,45121 claims |
| PfizerEliquis, Paxlovid | $134 | $20,29227 claims |
| AstraZenecaSymbicort | $37 | $6,48324 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 233 medical providers in West Virginia.
Other medical in Spencer
- Katherine BoggsSouth Charleston$46K
- Lowell LarewMorgantown$31K
- Katie CarpenterSouth Charleston$26K
- Lauren DillonBeckley$18K
- Angela HagerFarmington$16K
- Brandon CaragCharleston$16K
- Scott EthridgeCharleston$16K
- Kellie HanselSouth Charleston$12K
- Matthew MaynardElkins$10K
- Mohammad YousafCharleston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.